RANDOLPH C. STEER - 07 Sep 2021 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role: Director
Signature: /s/ Brenda S. Furlow as Attorney-in-Fact for Randolph C. Steer pursuant to Power of Attorney previously filed
Issuer symbol: TECH
Transactions as of: 07 Sep 2021
Net transactions value: -$3,363,143
Form type: 4
Filing time: 09 Sep 2021, 16:26:56 UTC
Next filing: 01 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TECH	Common Stock	Options Exercise	$349,560	+4,000	+78%	$87.39	9,112	07 Sep 2021	Direct
transaction	TECH	Common Stock	Options Exercise	$367,120	+4,000	+44%	$91.78	13,112	07 Sep 2021	Direct
transaction	TECH	Common Stock	Sale	$1,477,046	-2,900	-22%	$509.33	10,212	07 Sep 2021	Direct	F1
transaction	TECH	Common Stock	Sale	$2,347,052	-4,600	-45%	$510.23	5,612	07 Sep 2021	Direct	F2
transaction	TECH	Common Stock	Sale	$255,725	-500	-8.9%	$511.45	5,112	07 Sep 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership
transaction	TECH	Stock Option (right to buy)	Options Exercise	$0	-4,000	-100%	$0.000000^*	0	07 Sep 2021	Common Stock	4,000	$87.39	Direct
transaction	TECH	Stock Option (right to buy)	Options Exercise	$0	-4,000	-100%	$0.000000^*	0	07 Sep 2021	Common Stock	4,000	$91.78	Direct
holding	TECH	Stock Option (right to buy)						4,260	07 Sep 2021	Common Stock	4,260	$87.34	Direct
holding	TECH	Stock Option (right to buy)						3,985	07 Sep 2021	Common Stock	3,985	$101.19	Direct
holding	TECH	Stock Option (right to buy)						3,125	07 Sep 2021	Common Stock	3,125	$125.05	Direct
holding	TECH	Stock Option (right to buy)						1,898	07 Sep 2021	Common Stock	1,898	$179.84	Direct
holding	TECH	Stock Option (right to buy)						2,011	07 Sep 2021	Common Stock	2,011	$201.64	Direct
holding	TECH	Stock Option (right to buy)						1,507	07 Sep 2021	Common Stock	1,507	$255.69	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $508.978 to $509.769, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $509.98 to $510.597, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $508.978 to $509.769, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $509.98 to $510.597, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.